(Reuters) – A federal jury Tuesday determined that CVS Health Corp (NYSE :), Walgreens boots Alliance (NASDAQ 🙂 Inc and Walmart, Inc were responsible for the growth of an opioid epidemic in Ohio. It was this first case the company has faced in connection with the U.S. drug crises.

Below is a listing of companies that are alleged to be involved in the crisis, as well as the settlements and judgments related to those companies. These allegations have been denied by the companies.

DRUG DISTRIBUTORS

Cardinal Health Inc (NYSE :), AmerisourceBergen Corp (NYSE 🙂 and McKesson Corp(NYSE 🙂

In July, the U.S. State Attorney General and attorneys representing local governments agreed to a $21 billion settlement to resolve thousands of lawsuits. If governments decide not to participate in the settlement, they could increase or decrease their case value.

The companies were brought before non-jury judges in Washington and West Virginia for their claims that they fuelled the epidemic. They are currently awaiting the decision of a West Virginia federal judge. A lawsuit brought by Washington State is currently under way.

PHARMACY CHAINS

CVS Health Corp. Walgreens Boots Alliance Walgreens Health Corp. Rite Aid (NYSE) Corp. and Walmart Inc

Settlement of claims that the New York County of Suffolk and Nassau had fuelled an epidemic in opioid addiction.

Walgreens, CVS, and Walmart are found guilty in Ohio by a Federal Jury on Nov. 23, of contributing to the epidemic in Ohio in two Ohio County.

DRUGS MANUFACTURERS

Purdue Pharma

The company was approved by the bankruptcy courts in September for an agreement that Purdue says is worth $10 Billion to end allegations it fuelled the opioid crisis. Purdue’s owners, the Sackler clan, have committed to contributing $4.3 billion.

Purdue admitted guilty in November 2020 to violating federal anti-kickback legislation, defrauding United States, and violating Food, Drug, and Cosmetic Act.

Johnson & Johnson (NYSE:)

In July, the government agreed to $5 billion as part of a settlement with drug distributors and state governments. The value of the settlement could fluctuate depending on who participates.

The Oklahoma Supreme Court reaffirmed a verdict of $465 million that the state had won after a 2019 trial.

Teva Pharmaceutical Industries (NYSE:) Ltd

On the eve for a trial in Ohio, Cuyahoga County and Summit agreed to $20 million cash payment and $25 million Suboxone treatment over three years.

-A California judge in November following a non-jury trial rejected claims by several large counties against Teva, J&J, Endo International (NASDAQ:) PLC and AbbVie Inc (NYSE:).